TrialEuropean journal of heart failure2022

Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial.

Susana Ravassa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.